The semaglutide and tirzepatide shortages are resolved as of May 2025, but many patients are now transitioning to liraglutide or dulaglutide for GLP-1 therapy. As a pharmacy, you’re on the front lines of ensuring these patients continue to see results. The challenge? Dulaglutide weight loss (3–6% body weight) falls far short of tirzepatide’s 20–25%. STAAR LABS’ SLM+ supplement bridges this gap, helping your patients achieve dramatic results. Here’s why SLM+ is a must-recommend with every prescription.

The Challenge: Dulaglutide vs. Tirzepatide Weight Loss Results

Tirzepatide has been a weight loss powerhouse:

Tirzepatide (15 mg weekly): Up to 25% body weight loss, or 50+ lbs (SURPASS trials).
Semaglutide (2.4 mg weekly): 20% body weight loss, or 40–50 lbs (STEP trials).

But dulaglutide and liraglutide lag behind:

Dulaglutide (4.5 mg weekly): Only 3–6% body weight loss, or 5–15 lbs.
Liraglutide (3.0 mg daily): 5–10% body weight loss, or 10–20 lbs.

Without support, patients switching to dulaglutide may see their weight loss stall, leading to frustration and non-adherence. Pharmacies and providers can help their patients succeed with SLM+.

SLM+: The Essential Boost for Liraglutide and Dulaglutide Weight Loss

SLM+ works with liraglutide and dulaglutide to deliver tirzepatide-level results:

Increases GLP-1 Production: Boosts GLP-1 levels by up to 25%, enhancing satiety.
Turbocharges Metabolism: GIP, accelerating fat burning.
Improves Insulin Sensitivity: Drives metabolic efficiency.
Reduces Nausea: Minimizes GI discomfort, improving adherence.

The addition of SLM+ to GLP-1 therapy may increase weight loss by up to 50%. Without SLM+, patients on dulaglutide alone may lose just 5–15 lbs, risking dissatisfaction.

What Patients Can Expect After Switching to Dulaglutide

Slower Weight Loss: Without SLM+, patients may lose only 3–6% of body weight, compared to 20–25% with tirzepatide.
Initial Side Effects: Nausea (up to 30%) and GI discomfort are common in the first 4–6 weeks. SLM+ reduces these side effects.
Risk of Giving Up: Disappointing results can lead to frustration and discontinuation.

Why Recommend SLM+ with Every Prescription?

Maximize Liraglutide and Dulaglutide Weight Loss: Achieve up to a 50% boost in weight loss, matching tirzepatide results.
Increase Patient Satisfaction: Results within 8–12 weeks keep patients motivated.
Reduce Complaints: SLM+ minimizes nausea, ensuring adherence and fewer calls about side effects.

Act Now to Support Your Patients

Don’t let the shortage resolution derail your patients’ weight loss journey. Recommend SLM+ with every dulaglutide and liraglutide prescription to ensure they achieve the results they deserve. Contact STAAR LABS at info@staarlabs.com to stock SLM+ and learn more about the GPS Protocols.

Medical Disclaimer: This blog is for informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any changes to your medications, supplements, or health regimen. Individual results may vary.

Supplement Disclaimer: Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Research & Innovation Disclosure: STAAR LABS conducts protocol development in collaboration with licensed providers and pharmacies. Our research focuses on combining nutraceutical and pharmaceutical interventions to enhance metabolic outcomes. Weight loss projections involving SLM+ are based on early observational feedback and theoretical mechanisms, not yet published in peer-reviewed clinical trials.